BioSpace News Archive

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (“FSD Pharma” or the “Company”), today announces that it received “Study May Proceed” letter for the Investigational New Drug (“IND”) application from the U.S. Food and Drug Administration (“FDA”) and “Notice of Authorization” from Health Canada for its Phase 2 clinical trial of FSD201.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Monday, September 12, 2022 at 12:30 p.m. E.T.

ResMed announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, beginning at approximately 8:45 a.m. at the Sheraton New York in New York City.

Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, today announced exciting new preclinical data from the University of Tennessee Graduate School of Medicine from its study on novel human chimeric antigen receptor-macrophages (CAR-M) as a potential therapeutic for amyloid clearance.

Iovance Biotherapeutics, Inc. announced the publication of abstracts reporting clinical data and trial design for tumor infiltrating lymphocyte cell therapies at the European Society for Medical Oncology Congress 2022 in Paris, France, September 9 – 13, 2022.

Adial Pharmaceuticals, Inc., announced that Purnovate, Inc., a subsidiary of Adial focused on developing novel molecules targeting the adenosine receptors for the treatment of major unmet medical needs, achieved positive in-vivo data from its study with mice treated with Purnovate’s PNV-6005 as a potential treatment for inflammatory bowel diseases.

Demonstrating another key achievement, Microbot Medical Inc. (Nasdaq: MBOT), continues to execute its objective of expanding its global intellectual property (IP) portfolio for the LIBERTY® Robotic System as a grant for two Design Patent Applications was issued by the European Patent Office (EPO), covering the LIBERTY Robotic System’s Robotic Drive and Remote Controller.

Pain Specialists of America is pleased to announce that Jacob Caylor, MD, DABA, has joined their team to provide patient care in the rapidly growing Cedar Park and Round Rock markets of the North Austin region in Texas.

Hovione, the leader in spray drying and particle engineering, announced that it has expanded its continuous manufacturing offering and services.

Immunomic Therapeutics, Inc., a privately-held clinical-stage biotechnology company pioneering the study of LAMP -mediated nucleic acid-based immunotherapy, announced the appointment of Frances Harrison as Senior Vice President, Regulatory Affairs.